Mesenchymal stem cells: Therapeutic option in ARDS, COPD, and COVID-19 patients
Description
Acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD) and COVID-19 have as a common characteristic the inflammatory lesion of the lung epithelium. The therapeutic options are associated with opportunistic infections
